XRX

Xerox Holdings Corp. is rated a speculative Buy, driven by the Pivot Formula: revenue stabilization, profitability improvement, and leverage reduction. Q2 revenue rose 22% on acquisition, but pro forma revenue declined 6.5%, highlighting the need for organic stabilization. Profitability for XRX improved with a 10.6% adjusted operating margin, though 6.6 points were due to a one-time tariff benefit; sustainable gains hinge on Lexmark synergies.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Xerox shares jump 11.5% in three months as the Lexmark deal, stronger cash flow, debt reduction and a raised 2026 outlook improve its growth profile.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Xerox's 64% six-month rally, back-to-back earnings beats, IDP push and improved liquidity support its investment appeal.

XRX's cost cuts, margin gains and debt reduction bolster its turnaround, but shrinking print demand and high leverage keep execution risk elevated.

Xerox raised its 2026 outlook after a Q2 beat as Lexmark synergies lifted margins, though revenue declines and cash flow remain key tests.

I maintain a Hold rating on Xerox Holdings as core print revenue remains in decline despite new product launches and Lexmark synergies. Q2 headline revenue growth was acquisition-driven; pro forma revenue declined 6.5%, and margin expansion was largely due to a one-time tariff benefit. The 9-Series launch and Lexmark integration offer margin and cost-saving potential, but evidence of sustainable improvement is still limited.

XRX surpasses Q2 estimates as Lexmark and tariff receivables lifted results, but shares fall despite stronger 2026 revenue and profit guidance.

Xerox Holdings Corporation delivered a strong Q2, with shares surging 35% on improved profitability, raised guidance, and a robust free cash flow outlook. XRX posted 22% y/y revenue growth to $1.92B, with product sales up 49% and gross margin expanding 720 bps to 35.8%. Management raised FY26 guidance: revenue to $7.6B, adjusted operating income to $555m-$605m, and free cash flow to $250m, reflecting confidence in the turnaround.